IRVINE, Calif., March 18 /PRNewswire/ -- Relsys International today announced the release of the Argus Safety Suite 5.0, the new standard in global Drug Safety & Risk Management systems. The Argus Safety Suite 5.0 is a full stack release.
Argus Safety 5.0 features important productivity and usability enhancements to the most widely used adverse events management system in the world. It also features ongoing performance enhancements to the highly stable and efficient Argus database, ensuring that pharma companies can rapidly process and manage all of their reporting obligations.
Argus Perceptive 5.0 is a leading risk management system, pioneering the Structured Signal Management (SSM) approach. Argus Perceptive 5.0 enables powerful risk assessments with greater data accuracy, ensuring that medical reviewers get advanced notice of signals and potentially leading to earlier risk identification. While adhering to the Structured Signal Management approach, pharma companies ensure that their surveillance teams follow the signal and risk management process according to company-defined SOPs within an integrated environment.
Bruce Palsulich, Chief Innovation & Strategy Officer at Relsys, commented, "Increasing regulatory scrutiny and greater physician/consumer awareness have led directly to a record number of adverse events reported to regulators. In fact, in the first quarter of 2008, the FDA received a record number of adverse event reports, 82% of which originated from manufacturers. Pharma companies are struggling to meet this burden and are increasingly looking to commercial drug safety databases to help manage their regulatory requirements. I believe this is exactly why more than 1 out of every 3 of the Top 100 pharma have selected Argus Safety from Relsys to manage their pharmacovigilance obligations." Palsulich continued, "Furthermore, pharma is learning that signal detection tools by
|SOURCE Relsys International|
Copyright©2009 PR Newswire.
All rights reserved